Tower Research Capital (TRC)’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-8,861
| Closed | -$99K | – | 6768 |
|
|
2022
Q4 | $99K | Sell |
8,861
-32,050
| -78% | -$358K | ﹤0.01% | 1860 |
|
|
2022
Q3 | $230K | Buy |
40,911
+38,093
| +1,352% | +$214K | ﹤0.01% | 1792 |
|
|
2022
Q2 | $12K | Buy |
2,818
+1,898
| +206% | +$8.08K | ﹤0.01% | 4337 |
|
|
2022
Q1 | $11K | Sell |
920
-973
| -51% | -$11.6K | ﹤0.01% | 4253 |
|
|
2021
Q4 | $34K | Buy |
1,893
+335
| +22% | +$6.02K | ﹤0.01% | 3121 |
|
|
2021
Q3 | $19K | Buy |
1,558
+247
| +19% | +$3.01K | ﹤0.01% | 3789 |
|
|
2021
Q2 | $23K | Buy |
1,311
+352
| +37% | +$6.18K | ﹤0.01% | 3781 |
|
|
2021
Q1 | $18K | Sell |
959
-2,521
| -72% | -$47.3K | ﹤0.01% | 3981 |
|
|
2020
Q4 | $65K | Sell |
3,480
-2,570
| -42% | -$48K | ﹤0.01% | 2832 |
|
|
2020
Q3 | $128K | Buy |
6,050
+4,792
| +381% | +$101K | ﹤0.01% | 2944 |
|
|
2020
Q2 | $36K | Buy |
+1,258
| New | +$36K | ﹤0.01% | 3319 |
|
|
2020
Q1 | – | Sell |
-431
| Closed | -$11K | – | 4206 |
|
|
2019
Q4 | $11K | Buy |
+431
| New | +$11K | ﹤0.01% | 2307 |
|